Tuesday, July 18, 2023

Piramal Pharma#39;s Rs 1,050 crore rights issue gets Sebi#39;s nod

Piramal Pharma#39;s Rs 1,050 crore rights issue gets Sebi#39;s nod The pharma firm, which filed draft papers with the regulator in March, obtained its observation letter on July 12, an update with the Securities and Exchange Board of India (Sebi) showed on Tuesday.

from Moneycontrol Business News https://ift.tt/YA2SUBP
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...